Commercial Channels

Biennial survey finds growing awareness of information options by consumers

Xerox subsidiary expands its call-center operations to include specialty reimbursement services

Survey shows that most digital channels are still experiments with little oversight or follow-through

With competing products and pricing pressure, the rare disease market is starting to resemble the conventional drug market

Latest SK&A pharmacy data outlines retail channel

While the biopharma industry continues to develop better treatment options, there is a stronger focus on more intensive patient engagement

Company will open a second call center, in Atlanta, GA, to provide support for patient-engagement and adherence programs

Adds another acquisition, Dataline Software, to beef up real-world evidence (RWE) capabilities

As new cancer drugs with promising efficacy but brutal costs enter the market, providers, payers and manufacturers are strategizing new payment approaches

Leading copay-coupon provider expands its patient services with private equity help

Do you know your J codes?

Company uses online media to promote fill rates by more than 50%

1.5-10% improvement in 'revenue capture' is possible

'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney

Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors

Acquisition builds on Dohmen's rare-disease business

Outsourced field sales is becoming only part of what CSOs are offering their pharma clients

Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management

Compliance issues around sampling will be featured at upcoming conference

As rare diseases have emerged as a market opportunity for pharma over the past several years, industry practices are beginning to stabilize

After patent expires, 'The industry has turned a corner'

Siren Interactive hires more executives, moves to downtown Chicago